Collectively, the efficacy of TIM-3 and PD-1 co-blockades in preventing HPD and reversing the tumor progression induced by HPD might rely on enhancing the function of CD8+TILs and TIDCs. This evidence concerns the gene HAVCR2 and neoplasm.